
JAMA Oncology
@jamaonc
JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
ID: 2811548749
http://ja.ma/tjamaoncology 15-09-2014 15:33:04
18,18K Tweet
47,47K Followers
513 Following


Most viewed this week from JAMA Oncology: Viewpoint discusses how "skimming the median" can exaggerate survival gains in clinical trials, underscoring the need to critically evaluate Kaplan-Meier curves alongside hazard ratios. ja.ma/45zBluy












Most viewed this week from JAMA Oncology: While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon. ja.ma/4jyRiED



From JAMA Internal Medicine: Mailed self-collection was effective for increasing #CervicalCancer screening participation among never- and under-screened women in a safety net health setting. ja.ma/442jwTH



Most viewed this week from JAMA Oncology: While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon. ja.ma/4dVJAU8



